Vitamin D Receptor and Megalin Gene Polymorphisms and Their Association With Obesity, Central Obesity and the Metabolic Syndrome View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2004-2013

ABSTRACT

The link between metabolic disturbances and vitamin D receptor (VDR) and MEGALIN (or LRP2) gene polymorphisms remains unclear, particularly among African-American adults. The associations of single nucleotide polymorphisms (SNPs) for VDR [rs1544410(BsmI:G/A), rs7975232(ApaI:A/C), rs731236(TaqI:G/A)] and MEGALIN [rs3755166:G/A,rs2075252:C/T, rs2228171:C/T] genes with incident and prevalent metabolic disturbances, including obesity, central obesity and metabolic syndrome (MetS) were evaluated. From 1,024 African-Americans participating in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS, Baltimore, MD, 2004-2013) study, 539 subjects were selected who had complete genetic data as well as covariates selected for metabolic outcomes at two consecutive examinations (visits 1 and 2) with a mean follow-up time of 4.64±0.93y. Haplotype (HAP) analyses generated polymorphism groups that were linked to incident and prevalent metabolic disturbances. Detailed Description Adiposity, especially central adiposity, is a key component of the metabolic syndrome (MetS), which is accompanied by hyperglycemia, elevated blood pressure, lower HDL cholesterol and hypertriglyceridemia.(Ford, et al., 2003,Grundy, 1999)_ENREF_4 MetS increases the risk of type 2 diabetes (T2D) and cardiovascular disease by 1.7- and 5-folds, respectively.(Alberti, et al., 2009,Ford, et al., 2003,Galassi, et al., 2006) MetS is heritable and polygenic.(Maes, et al., 1997) Genetic variability contributes to 16%-85% of changes in Body Mass Index (BMI)(Yang, et al., 2007) and 37%-81% in waist circumference (WC) (e.g.(Ochs-Balcom, et al., 2011)). MetS is a major public health concern, increasing all-cause mortality rates, disability and health care costs.(Appels and Vandenbroucke, 2006,Bender, et al., 2006,Colditz, 1999,Doig, 2004,Ferrucci and Alley, 2007,Hill, et al., 2004,Solomon and Manson, 1997,Stevens, 2000,Wolf and Colditz, 1998) Obesity is implicated in the etiology of vitamin D deficiency. Serum 25-hydroxyvitamin D [25(OH)D] concentration correlates inversely with adiposity.(Beydoun, et al., 2010,Dorjgochoo, et al., 2012) Conversely, vitamin D3 may play a role in obesity by modulating intracellular calcium homeostasis, because higher intracellular calcium triggers lipogenesis and suppresses lipolysis.(Zemel, 2003) Many organs express vitamin D receptor (VDR), a part of the nuclear hormone receptor super-family. The VDR-1,25(OH)2D3 complex modulates transcription of vitamin D responsive genes(Kato, 2000) and influences adipocyte differentiation both in vitro and in vivo.(Wood, 2008) Epidemiological studies have shown associations of VDR gene polymorphisms with adiposity and related metabolic disorders.(Filus, et al., 2008,Grundberg, et al., 2004,Gu, et al., 2009,Ochs-Balcom, et al., 2011,Oh and Barrett-Connor, 2002,Ortlepp, et al., 2001,Ortlepp, et al., 2003,Speer, et al., 2001,Ye, et al., 2001) However, studies specifically examining adiposity outcomes either had small sample sizes (<400), (e.g.(Filus, et al., 2008,Grundberg, et al., 2004,Speer, et al., 2001)) or were restricted to one sex, (e.g. (Grundberg, et al., 2004,Ochs-Balcom, et al., 2011)) but more importantly were all cross-sectional or case-control by design.(Filus, et al., 2008,Grundberg, et al., 2004,Gu, et al., 2009,Ochs-Balcom, et al., 2011,Oh and Barrett-Connor, 2002,Ortlepp, et al., 2001,Ortlepp, et al., 2003,Speer, et al., 2001,Ye, et al., 2001) MEGALIN (aka low-density lipoprotein receptor-related protein-2 [LRP-2]), is the endocytic vitamin D-binding protein receptor which allows vitamin D entry into cells and whose expression is directly regulated by both vitamin D (Gressner, et al., 2008)) and vitamin A.(Liu, et al., 1998) MEGALIN may influences obesity by mediating leptin transport through the blood-brain barrier and modulating leptin signaling,(Dietrich, et al., 2008) or by facilitating transcytosis of its precursor hormone thyroglobulin.(Lisi, et al., 2005) Collectively, leptin and thyroid hormones affect adiposity through energy metabolism regulation.(Beydoun, et al., 2011) MEGALIN acting also as the receptor for sex-hormone binding globulin (SHBG) may play a role in the interaction between estrogen, vitamin D and intracellular calcium in adipocytes, resulting in sex-specific effects of MEGALIN polymorphisms on obesity phenotypes.(Ding, et al., 2008) In this study, it is hypothesized that selected polymorphisms in VDR and MEGALIN genes have sex-specific associations with several key metabolic disturbances in a longitudinal study of African-American urban adults. More... »

URL

https://clinicaltrials.gov/show/NCT03279432

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The link between metabolic disturbances and vitamin D receptor (VDR) and MEGALIN (or LRP2) gene polymorphisms remains unclear, particularly among African-American adults. The associations of single nucleotide polymorphisms (SNPs) for VDR [rs1544410(BsmI:G/A), rs7975232(ApaI:A/C), rs731236(TaqI:G/A)] and MEGALIN [rs3755166:G/A,rs2075252:C/T, rs2228171:C/T] genes with incident and prevalent metabolic disturbances, including obesity, central obesity and metabolic syndrome (MetS) were evaluated. From 1,024 African-Americans participating in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS, Baltimore, MD, 2004-2013) study, 539 subjects were selected who had complete genetic data as well as covariates selected for metabolic outcomes at two consecutive examinations (visits 1 and 2) with a mean follow-up time of 4.64\u00b10.93y. Haplotype (HAP) analyses generated polymorphism groups that were linked to incident and prevalent metabolic disturbances.\n\nDetailed Description\nAdiposity, especially central adiposity, is a key component of the metabolic syndrome (MetS), which is accompanied by hyperglycemia, elevated blood pressure, lower HDL cholesterol and hypertriglyceridemia.(Ford, et al., 2003,Grundy, 1999)_ENREF_4 MetS increases the risk of type 2 diabetes (T2D) and cardiovascular disease by 1.7- and 5-folds, respectively.(Alberti, et al., 2009,Ford, et al., 2003,Galassi, et al., 2006) MetS is heritable and polygenic.(Maes, et al., 1997) Genetic variability contributes to 16%-85% of changes in Body Mass Index (BMI)(Yang, et al., 2007) and 37%-81% in waist circumference (WC) (e.g.(Ochs-Balcom, et al., 2011)). MetS is a major public health concern, increasing all-cause mortality rates, disability and health care costs.(Appels and Vandenbroucke, 2006,Bender, et al., 2006,Colditz, 1999,Doig, 2004,Ferrucci and Alley, 2007,Hill, et al., 2004,Solomon and Manson, 1997,Stevens, 2000,Wolf and Colditz, 1998) Obesity is implicated in the etiology of vitamin D deficiency. Serum 25-hydroxyvitamin D [25(OH)D] concentration correlates inversely with adiposity.(Beydoun, et al., 2010,Dorjgochoo, et al., 2012) Conversely, vitamin D3 may play a role in obesity by modulating intracellular calcium homeostasis, because higher intracellular calcium triggers lipogenesis and suppresses lipolysis.(Zemel, 2003) Many organs express vitamin D receptor (VDR), a part of the nuclear hormone receptor super-family. The VDR-1,25(OH)2D3 complex modulates transcription of vitamin D responsive genes(Kato, 2000) and influences adipocyte differentiation both in vitro and in vivo.(Wood, 2008) Epidemiological studies have shown associations of VDR gene polymorphisms with adiposity and related metabolic disorders.(Filus, et al., 2008,Grundberg, et al., 2004,Gu, et al., 2009,Ochs-Balcom, et al., 2011,Oh and Barrett-Connor, 2002,Ortlepp, et al., 2001,Ortlepp, et al., 2003,Speer, et al., 2001,Ye, et al., 2001) However, studies specifically examining adiposity outcomes either had small sample sizes (<400), (e.g.(Filus, et al., 2008,Grundberg, et al., 2004,Speer, et al., 2001)) or were restricted to one sex, (e.g. (Grundberg, et al., 2004,Ochs-Balcom, et al., 2011)) but more importantly were all cross-sectional or case-control by design.(Filus, et al., 2008,Grundberg, et al., 2004,Gu, et al., 2009,Ochs-Balcom, et al., 2011,Oh and Barrett-Connor, 2002,Ortlepp, et al., 2001,Ortlepp, et al., 2003,Speer, et al., 2001,Ye, et al., 2001) MEGALIN (aka low-density lipoprotein receptor-related protein-2 [LRP-2]), is the endocytic vitamin D-binding protein receptor which allows vitamin D entry into cells and whose expression is directly regulated by both vitamin D (Gressner, et al., 2008)) and vitamin A.(Liu, et al., 1998) MEGALIN may influences obesity by mediating leptin transport through the blood-brain barrier and modulating leptin signaling,(Dietrich, et al., 2008) or by facilitating transcytosis of its precursor hormone thyroglobulin.(Lisi, et al., 2005) Collectively, leptin and thyroid hormones affect adiposity through energy metabolism regulation.(Beydoun, et al., 2011) MEGALIN acting also as the receptor for sex-hormone binding globulin (SHBG) may play a role in the interaction between estrogen, vitamin D and intracellular calcium in adipocytes, resulting in sex-specific effects of MEGALIN polymorphisms on obesity phenotypes.(Ding, et al., 2008) In this study, it is hypothesized that selected polymorphisms in VDR and MEGALIN genes have sex-specific associations with several key metabolic disturbances in a longitudinal study of African-American urban adults.", 
    "endDate": "2013-07-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03279432", 
    "keywords": [
      "vitamin", 
      "gene polymorphism", 
      "association", 
      "Abdominal Obesity", 
      "metabolic syndrome", 
      "metabolic disturbance", 
      "Calcitriol Receptor", 
      "Low Density Lipoprotein Receptor-Related Protein-2", 
      "African American adult", 
      "single nucleotide polymorphism", 
      "C/T", 
      "gene", 
      "incident", 
      "obesity", 
      "MetS", 
      "African american", 
      "Baltimore", 
      "MD", 
      "genetic data", 
      "covariates", 
      "metabolic outcome", 
      "examination", 
      "follow-up time", 
      "haplotype", 
      "HAP", 
      "adiposity", 
      "central adiposity", 
      "key component", 
      "hyperglycemia", 
      "elevated blood pressure", 
      "HDL cholesterol", 
      "hypertriglyceridemia", 
      "Ford", 
      "risk", 
      "type 2 diabetes", 
      "T2D", 
      "cardiovascular disease", 
      "MAE", 
      "genetic variability", 
      "body mass index", 
      "Yang", 
      "waist circumference", 
      "major public health concern", 
      "all-cause mortality", 
      "disability", 
      "health care cost", 
      "hill", 
      "Solomon", 
      "Steven", 
      "wolf", 
      "etiology", 
      "vitamin D deficiency", 
      "serum", 
      "OH", 
      "Attention", 
      "Cholecalciferol", 
      "intracellular calcium homeostasis", 
      "intracellular calcium", 
      "lipogenesis", 
      "lipolysis", 
      "organ", 
      "nuclear hormone receptor", 
      "receptor", 
      "complex", 
      "transcription", 
      "responsive gene", 
      "adipocyte differentiation", 
      "vitro", 
      "vivo", 
      "wood", 
      "Epidemiologic Study", 
      "shown association", 
      "vitamin D receptor gene", 
      "related metabolic disorder", 
      "GUS", 
      "Barrett", 
      "YES", 
      "small sample size", 
      "sex", 
      "low-density lipoprotein receptor-related protein", 
      "Vitamin D-Binding Protein", 
      "cell", 
      "expression", 
      "Liu", 
      "transport", 
      "blood-brain barrier", 
      "leptin signaling", 
      "Dietrich", 
      "transcytosis", 
      "thyroglobulin", 
      "leptin", 
      "thyroid hormone", 
      "Energy Metabolism", 
      "Sex Hormone-Binding Globulin", 
      "estrogen", 
      "adipocytes", 
      "sex-specific effect", 
      "obesity phenotype", 
      "Ding", 
      "specific association", 
      "longitudinal study"
    ], 
    "name": "Vitamin D Receptor and Megalin Gene Polymorphisms and Their Association With Obesity, Central Obesity and the Metabolic Syndrome", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03279432"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00025.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.419475.a", 
        "type": "Organization"
      }
    ], 
    "startDate": "2004-08-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1002/j.1550-8528.1998.tb00322.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001694101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11745-003-1044-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002289890", 
          "https://doi.org/10.1007/s11745-003-1044-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/eje.0.1440385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002439544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/eje.0.1450181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007922135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neurobiolaging.2007.01.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010061399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1464-5491.2001.00585.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010293499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.109.192644", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011029623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1464-5491.2003.00971.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011731435"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amepre.2004.06.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015320942"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/meta.2002.29969", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016697496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cca.2007.12.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019418286"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc062590", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020939154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/eje.0.1500323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023136910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1753-4887.2007.00004.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026267722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1753-4887.2000.tb01832.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027120020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.167.8.750", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028063793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2362.1998.00253.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029234327"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neurobiolaging.2011.05.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031387036"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/aps.2009.169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034071631", 
          "https://doi.org/10.1038/aps.2009.169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(99)00211-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035030591"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjmed.2006.02.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035257029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3945/ajcn.2010.29986", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035523776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/epirev/mxm004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038061261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1025635913927", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040055293", 
          "https://doi.org/10.1023/a:1025635913927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ijo.2011.246", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044926041", 
          "https://doi.org/10.1038/ijo.2011.246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jclinepi.2006.01.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044992727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.52.9.2346", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049391484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13685530802273426", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049626250"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.mce.2005.03.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050206667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.ccm.0000119934.01548.af", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051217264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.23311", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053574486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.jbchem.a022662", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059961463"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005768-199911001-00026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060233079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2010-0410", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064292078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajcn/66.4.1044s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083156499"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03279432"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03279432'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03279432'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03279432'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03279432'


 

This table displays all metadata directly associated to this object as RDF triples.

229 TRIPLES      16 PREDICATES      151 URIs      110 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03279432 schema:about anzsrc-for:3053
2 schema:description The link between metabolic disturbances and vitamin D receptor (VDR) and MEGALIN (or LRP2) gene polymorphisms remains unclear, particularly among African-American adults. The associations of single nucleotide polymorphisms (SNPs) for VDR [rs1544410(BsmI:G/A), rs7975232(ApaI:A/C), rs731236(TaqI:G/A)] and MEGALIN [rs3755166:G/A,rs2075252:C/T, rs2228171:C/T] genes with incident and prevalent metabolic disturbances, including obesity, central obesity and metabolic syndrome (MetS) were evaluated. From 1,024 African-Americans participating in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS, Baltimore, MD, 2004-2013) study, 539 subjects were selected who had complete genetic data as well as covariates selected for metabolic outcomes at two consecutive examinations (visits 1 and 2) with a mean follow-up time of 4.64±0.93y. Haplotype (HAP) analyses generated polymorphism groups that were linked to incident and prevalent metabolic disturbances. Detailed Description Adiposity, especially central adiposity, is a key component of the metabolic syndrome (MetS), which is accompanied by hyperglycemia, elevated blood pressure, lower HDL cholesterol and hypertriglyceridemia.(Ford, et al., 2003,Grundy, 1999)_ENREF_4 MetS increases the risk of type 2 diabetes (T2D) and cardiovascular disease by 1.7- and 5-folds, respectively.(Alberti, et al., 2009,Ford, et al., 2003,Galassi, et al., 2006) MetS is heritable and polygenic.(Maes, et al., 1997) Genetic variability contributes to 16%-85% of changes in Body Mass Index (BMI)(Yang, et al., 2007) and 37%-81% in waist circumference (WC) (e.g.(Ochs-Balcom, et al., 2011)). MetS is a major public health concern, increasing all-cause mortality rates, disability and health care costs.(Appels and Vandenbroucke, 2006,Bender, et al., 2006,Colditz, 1999,Doig, 2004,Ferrucci and Alley, 2007,Hill, et al., 2004,Solomon and Manson, 1997,Stevens, 2000,Wolf and Colditz, 1998) Obesity is implicated in the etiology of vitamin D deficiency. Serum 25-hydroxyvitamin D [25(OH)D] concentration correlates inversely with adiposity.(Beydoun, et al., 2010,Dorjgochoo, et al., 2012) Conversely, vitamin D3 may play a role in obesity by modulating intracellular calcium homeostasis, because higher intracellular calcium triggers lipogenesis and suppresses lipolysis.(Zemel, 2003) Many organs express vitamin D receptor (VDR), a part of the nuclear hormone receptor super-family. The VDR-1,25(OH)2D3 complex modulates transcription of vitamin D responsive genes(Kato, 2000) and influences adipocyte differentiation both in vitro and in vivo.(Wood, 2008) Epidemiological studies have shown associations of VDR gene polymorphisms with adiposity and related metabolic disorders.(Filus, et al., 2008,Grundberg, et al., 2004,Gu, et al., 2009,Ochs-Balcom, et al., 2011,Oh and Barrett-Connor, 2002,Ortlepp, et al., 2001,Ortlepp, et al., 2003,Speer, et al., 2001,Ye, et al., 2001) However, studies specifically examining adiposity outcomes either had small sample sizes (<400), (e.g.(Filus, et al., 2008,Grundberg, et al., 2004,Speer, et al., 2001)) or were restricted to one sex, (e.g. (Grundberg, et al., 2004,Ochs-Balcom, et al., 2011)) but more importantly were all cross-sectional or case-control by design.(Filus, et al., 2008,Grundberg, et al., 2004,Gu, et al., 2009,Ochs-Balcom, et al., 2011,Oh and Barrett-Connor, 2002,Ortlepp, et al., 2001,Ortlepp, et al., 2003,Speer, et al., 2001,Ye, et al., 2001) MEGALIN (aka low-density lipoprotein receptor-related protein-2 [LRP-2]), is the endocytic vitamin D-binding protein receptor which allows vitamin D entry into cells and whose expression is directly regulated by both vitamin D (Gressner, et al., 2008)) and vitamin A.(Liu, et al., 1998) MEGALIN may influences obesity by mediating leptin transport through the blood-brain barrier and modulating leptin signaling,(Dietrich, et al., 2008) or by facilitating transcytosis of its precursor hormone thyroglobulin.(Lisi, et al., 2005) Collectively, leptin and thyroid hormones affect adiposity through energy metabolism regulation.(Beydoun, et al., 2011) MEGALIN acting also as the receptor for sex-hormone binding globulin (SHBG) may play a role in the interaction between estrogen, vitamin D and intracellular calcium in adipocytes, resulting in sex-specific effects of MEGALIN polymorphisms on obesity phenotypes.(Ding, et al., 2008) In this study, it is hypothesized that selected polymorphisms in VDR and MEGALIN genes have sex-specific associations with several key metabolic disturbances in a longitudinal study of African-American urban adults.
3 schema:endDate 2013-07-01T00:00:00Z
4 schema:keywords Abdominal Obesity
5 African American adult
6 African american
7 Attention
8 Baltimore
9 Barrett
10 C/T
11 Calcitriol Receptor
12 Cholecalciferol
13 Dietrich
14 Ding
15 Energy Metabolism
16 Epidemiologic Study
17 Ford
18 GUS
19 HAP
20 HDL cholesterol
21 Liu
22 Low Density Lipoprotein Receptor-Related Protein-2
23 MAE
24 MD
25 MetS
26 OH
27 Sex Hormone-Binding Globulin
28 Solomon
29 Steven
30 T2D
31 Vitamin D-Binding Protein
32 YES
33 Yang
34 adipocyte differentiation
35 adipocytes
36 adiposity
37 all-cause mortality
38 association
39 blood-brain barrier
40 body mass index
41 cardiovascular disease
42 cell
43 central adiposity
44 complex
45 covariates
46 disability
47 elevated blood pressure
48 estrogen
49 etiology
50 examination
51 expression
52 follow-up time
53 gene
54 gene polymorphism
55 genetic data
56 genetic variability
57 haplotype
58 health care cost
59 hill
60 hyperglycemia
61 hypertriglyceridemia
62 incident
63 intracellular calcium
64 intracellular calcium homeostasis
65 key component
66 leptin
67 leptin signaling
68 lipogenesis
69 lipolysis
70 longitudinal study
71 low-density lipoprotein receptor-related protein
72 major public health concern
73 metabolic disturbance
74 metabolic outcome
75 metabolic syndrome
76 nuclear hormone receptor
77 obesity
78 obesity phenotype
79 organ
80 receptor
81 related metabolic disorder
82 responsive gene
83 risk
84 serum
85 sex
86 sex-specific effect
87 shown association
88 single nucleotide polymorphism
89 small sample size
90 specific association
91 thyroglobulin
92 thyroid hormone
93 transcription
94 transcytosis
95 transport
96 type 2 diabetes
97 vitamin
98 vitamin D deficiency
99 vitamin D receptor gene
100 vitro
101 vivo
102 waist circumference
103 wolf
104 wood
105 schema:name Vitamin D Receptor and Megalin Gene Polymorphisms and Their Association With Obesity, Central Obesity and the Metabolic Syndrome
106 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03279432
107 schema:sdDatePublished 2019-03-07T15:27
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher Na27b425567164d989cc991439f608ca3
110 schema:sponsor https://www.grid.ac/institutes/grid.419475.a
111 schema:startDate 2004-08-01T00:00:00Z
112 schema:subjectOf sg:pub.10.1007/s11745-003-1044-6
113 sg:pub.10.1023/a:1025635913927
114 sg:pub.10.1038/aps.2009.169
115 sg:pub.10.1038/ijo.2011.246
116 https://doi.org/10.1001/archinte.167.8.750
117 https://doi.org/10.1002/ijc.23311
118 https://doi.org/10.1002/j.1550-8528.1998.tb00322.x
119 https://doi.org/10.1016/j.amepre.2004.06.010
120 https://doi.org/10.1016/j.amjmed.2006.02.031
121 https://doi.org/10.1016/j.cca.2007.12.011
122 https://doi.org/10.1016/j.jclinepi.2006.01.006
123 https://doi.org/10.1016/j.mce.2005.03.009
124 https://doi.org/10.1016/j.neurobiolaging.2007.01.008
125 https://doi.org/10.1016/j.neurobiolaging.2011.05.008
126 https://doi.org/10.1016/s0002-9149(99)00211-8
127 https://doi.org/10.1046/j.1365-2362.1998.00253.x
128 https://doi.org/10.1046/j.1464-5491.2001.00585.x
129 https://doi.org/10.1046/j.1464-5491.2003.00971.x
130 https://doi.org/10.1053/meta.2002.29969
131 https://doi.org/10.1056/nejmc062590
132 https://doi.org/10.1080/13685530802273426
133 https://doi.org/10.1093/ajcn/66.4.1044s
134 https://doi.org/10.1093/epirev/mxm004
135 https://doi.org/10.1093/oxfordjournals.jbchem.a022662
136 https://doi.org/10.1097/00005768-199911001-00026
137 https://doi.org/10.1097/01.ccm.0000119934.01548.af
138 https://doi.org/10.1111/j.1753-4887.2000.tb01832.x
139 https://doi.org/10.1111/j.1753-4887.2007.00004.x
140 https://doi.org/10.1161/circulationaha.109.192644
141 https://doi.org/10.1210/jc.2010-0410
142 https://doi.org/10.1530/eje.0.1440385
143 https://doi.org/10.1530/eje.0.1450181
144 https://doi.org/10.1530/eje.0.1500323
145 https://doi.org/10.2337/diabetes.52.9.2346
146 https://doi.org/10.3945/ajcn.2010.29986
147 schema:url https://clinicaltrials.gov/show/NCT03279432
148 sgo:license sg:explorer/license/
149 sgo:sdDataset clinical_trials
150 rdf:type schema:MedicalStudy
151 Na27b425567164d989cc991439f608ca3 schema:name Springer Nature - SN SciGraph project
152 rdf:type schema:Organization
153 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
154 rdf:type schema:DefinedTerm
155 sg:pub.10.1007/s11745-003-1044-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002289890
156 https://doi.org/10.1007/s11745-003-1044-6
157 rdf:type schema:CreativeWork
158 sg:pub.10.1023/a:1025635913927 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040055293
159 https://doi.org/10.1023/a:1025635913927
160 rdf:type schema:CreativeWork
161 sg:pub.10.1038/aps.2009.169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034071631
162 https://doi.org/10.1038/aps.2009.169
163 rdf:type schema:CreativeWork
164 sg:pub.10.1038/ijo.2011.246 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044926041
165 https://doi.org/10.1038/ijo.2011.246
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1001/archinte.167.8.750 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028063793
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1002/ijc.23311 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053574486
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1002/j.1550-8528.1998.tb00322.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001694101
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1016/j.amepre.2004.06.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015320942
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1016/j.amjmed.2006.02.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035257029
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/j.cca.2007.12.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019418286
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/j.jclinepi.2006.01.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044992727
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/j.mce.2005.03.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050206667
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/j.neurobiolaging.2007.01.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010061399
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/j.neurobiolaging.2011.05.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031387036
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/s0002-9149(99)00211-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035030591
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1046/j.1365-2362.1998.00253.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029234327
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1046/j.1464-5491.2001.00585.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010293499
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1046/j.1464-5491.2003.00971.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011731435
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1053/meta.2002.29969 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016697496
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1056/nejmc062590 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020939154
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1080/13685530802273426 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049626250
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1093/ajcn/66.4.1044s schema:sameAs https://app.dimensions.ai/details/publication/pub.1083156499
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1093/epirev/mxm004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038061261
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1093/oxfordjournals.jbchem.a022662 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059961463
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1097/00005768-199911001-00026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060233079
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1097/01.ccm.0000119934.01548.af schema:sameAs https://app.dimensions.ai/details/publication/pub.1051217264
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1111/j.1753-4887.2000.tb01832.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027120020
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1111/j.1753-4887.2007.00004.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026267722
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1161/circulationaha.109.192644 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011029623
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1210/jc.2010-0410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064292078
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1530/eje.0.1440385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002439544
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1530/eje.0.1450181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007922135
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1530/eje.0.1500323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023136910
224 rdf:type schema:CreativeWork
225 https://doi.org/10.2337/diabetes.52.9.2346 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049391484
226 rdf:type schema:CreativeWork
227 https://doi.org/10.3945/ajcn.2010.29986 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035523776
228 rdf:type schema:CreativeWork
229 https://www.grid.ac/institutes/grid.419475.a schema:Organization
 




Preview window. Press ESC to close (or click here)


...